Skip to main content
Glama

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. First observed

TDQS

A4.9/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations declare readOnlyHint=true, openWorldHint=true, idempotentHint=true, destructiveHint=false. The description adds behavioral context: it makes a parallel call, handles off-calendar fiscal years, sorts results by primary metric, and returns paired data with citation URIs. No contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Description is dense and front-loaded with key use cases. However, it could be slightly more structured (e.g., separating company vs drug details) to improve readability while maintaining conciseness.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the tool's simplicity (2 parameters, no output schema), the description covers all necessary context: entity types, data sources, sorting, return format, and efficiency benefits. An agent can correctly select and invoke this tool.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% with descriptions for both parameters. The description enhances understanding by specifying that 'type' determines data source (company=SEC EDGAR, drug=FAERS) and 'values' format (tickers/CIKs for company, names for drug).

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

Description clearly states the tool performs side-by-side comparisons of 2-5 companies or drugs. It provides specific example phrases like 'which is bigger' and 'rank these companies', distinguishing it from single-entity tools like entity_profile.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicitly instructs to prefer this over sequential single-pack lookups when comparing entities. It details when to use each type (company vs drug) and what data is retrieved (SEC filings for companies, FAERS for drugs).

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation3/5

Many tools are clearly distinct, but the existence of multiple ask_pipeworx variants (standard, beta, grounded) and the overlapping check_risk/lookup_ip tools create meaningful selection ambiguity. Description differentiation helps but doesn't fully resolve it.

Naming Consistency3/5

All names use snake_case, but conventions vary between verb-noun (lookup_ip, compare_entities), noun phrases (entity_profile, recent_alerts), and domain-prefixed names (polymarket_edges, pipeworx_trending). It's readable but not a consistent pattern.

Tool Count2/5

At 33 tools the surface is large, with duplicated ask_pipeworx variants, a modest IP lookup core, and a large number of meta/management tools (memory, subscriptions, onboarding, feedback). Even with a broad scope this feels overloaded, and it is well above the 25+ threshold.

Completeness4/5

The query domain is well covered: entity profiles, comparison, claim validation, deep research, changes, plus memory and subscription management. Minor gaps exist (no direct subscription update, no raw citation fetch utility), but agents can work around them.